|Articles|June 13, 2014
Society for Clinical Research Sites' Global Impact Partner Program Welcomes Four New Members
SCRS Global Impact Partner program announced it has gained four new members since April 1.
Advertisement
The Society for Clinical Research Sites' (SCRS) Global Impact Partner (GIP) program at announced it has gained four new members since April 1. These companies are INC Research, inVentiv Health, Novartis and Sanofi, which now brings the total number of companies in the initiative to 25. Global Impact Partners participate on the SCRS Global Impact Board at an executive level and work in tandem with the SCRS Leadership Council. They serve as strategic partners and help set key initiatives for the Society to elevate site performance and enhance site sustainability.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5